Company Filing History:
Years Active: 2024-2025
Title: Reto Bertolini: Innovator in Tricyclo-DNA Technologies
Introduction
Reto Bertolini is a notable inventor based in Liebefeld, Switzerland. He has made significant contributions to the field of nucleic acid chemistry, particularly through his innovative work on tricyclo-DNA nucleosides. With a total of 2 patents, Bertolini's inventions are paving the way for advancements in medical treatments.
Latest Patents
Bertolini's latest patents include two groundbreaking inventions. The first patent focuses on "Tricyclo-DNA nucleoside precursors and processes for preparing the same." This invention relates to a process for preparing tc-DNA nucleoside precursors, which are essential for creating tc-DNA nucleosides and oligonucleotides. The process involves the use of a carbene precursor and outlines methods for preparing various tc-DNA nucleoside precursors.
The second patent is titled "Modified oligomeric compounds comprising tricyclo-DNA nucleosides and uses thereof." This invention describes a composition that includes an oligomeric compound made up of one or more tc-DNA nucleosides linked to lipid moieties. These compounds have potential applications in pharmaceutical compositions for the prevention or treatment of neuromuscular or musculoskeletal diseases, such as Duchenne muscular dystrophy or Steinert disease.
Career Highlights
Reto Bertolini is currently associated with Synthena AG, a company that focuses on innovative solutions in the field of biotechnology. His work at Synthena AG has allowed him to explore and develop his ideas further, contributing to the advancement of nucleic acid technologies.
Collaborations
Bertolini has collaborated with notable colleagues, including Branislav Dugovic and Wolfgang Andreas Renner. These collaborations have fostered a productive environment for innovation and research in their respective fields.
Conclusion
Reto Bertolini's contributions to the field of tricyclo-DNA technologies highlight his role as an influential inventor. His patents not only advance scientific knowledge but also hold promise for future medical applications.